Pharmacoinformatics and molecular dynamics simulation approach to identify anti-diarrheal potentials of Centella asiatica (L.) Urb. against Vibrio cholerae
暂无分享,去创建一个
A. Al-Mamun | M. Salimullah | C. A. Keya | Ishtiaque Ahammad | Arittra Bhattacharjee | K. C. Das | Z. Chowdhury | Sheikh Sunzid Ahmed | F. Akter | Shahanoor Hossain
[1] M. A. Ali,et al. Anticancer potential of phytochemicals from Oroxylum indicum targeting Lactate Dehydrogenase A through bioinformatic approach , 2022, Toxicology reports.
[2] Shumneva Shrestha,et al. Cholera amid COVID-19: Call from three nations; India, Bangladesh, and Nepal , 2022, Annals of Medicine and Surgery.
[3] M. O. Rahman,et al. Anti-angiogenic potential of bioactive phytochemicals from Helicteres isora targeting VEGFR-2 to fight cancer through molecular docking and molecular dynamics simulation , 2022, Journal of biomolecular structure & dynamics.
[4] J. Ribeiro-Filho,et al. Potentiation of the Activity of Antibiotics against ATCC and MDR Bacterial Strains with (+)-α-Pinene and (-)-Borneol , 2022, BioMed research international.
[5] A. Vaziri,et al. Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis , 2022, Antimicrobial resistance and infection control.
[6] G. Batiha,et al. Ethnobotany, phytochemistry, pharmacology, and toxicity of Centella asiatica (L.) Urban: A comprehensive review , 2021, Phytotherapy research : PTR.
[7] J. Mandal,et al. In-vitro study of the effect of Centella asiatica on cholera toxin production and the gene expression level of ctxA gene in Vibrio cholerae isolates. , 2021, Journal of ethnopharmacology.
[8] Mohammad Kawsar Sharif Siam,et al. In silico drug design and molecular docking studies targeting Akt1 (RAC-alpha serine/threonine-protein kinase) and Akt2 (RAC-beta serine/threonine-protein kinase) proteins and investigation of CYP (cytochrome P450) inhibitors against MAOB (monoamine oxidase B) for OSCC (oral squamous cell carcinoma) , 2020, Journal of biomolecular structure & dynamics.
[9] B. Salehi,et al. Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications , 2020, BMC Complementary Medicine and Therapies.
[10] F. Ameen,et al. Gold nanoparticles synthesised by flavonoid tricetin as a potential antibacterial nanomedicine to treat respiratory infections causing opportunistic bacterial pathogens. , 2019, Microbial pathogenesis.
[11] Kun Hu,et al. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. , 2019, Toxicology and applied pharmacology.
[12] Olivier Michielin,et al. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..
[13] Zbigniew Dutkiewicz,et al. Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors , 2018, Bioinorganic chemistry and applications.
[14] Md Kamal Hossain,et al. Molecular docking and dynamics of Nickel-Schiff base complexes for inhibiting β-lactamase of Mycobacterium tuberculosis , 2018, In Silico Pharmacology.
[15] C. Lipinski,et al. The rule of five should not impede anti-parasitic drug development , 2017, International journal for parasitology. Drugs and drug resistance.
[16] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[17] T. Hagen,et al. Demonstration of AutoDock as an Educational Tool for Drug Discovery. , 2017, Journal of chemical education.
[18] Chuan-Tien Hung,et al. Control of the negative IRES trans-acting factor KHSRP by ubiquitination , 2016, Nucleic acids research.
[19] R. Kasimani,et al. Comparative modelling and molecular docking of nitrate reductase from Bacillus weihenstephanensis (DS45) , 2016 .
[20] Vincent Zoete,et al. A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules , 2016, ChemMedChem.
[21] Douglas E. V. Pires,et al. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.
[22] Aditi Gangopadhyay,et al. Identification of inhibitors against the potential ligandable sites in the active cholera toxin , 2015, Comput. Biol. Chem..
[23] Vinícius Gonçalves Maltarollo,et al. Applying machine learning techniques for ADME-Tox prediction: a review , 2015, Expert opinion on drug metabolism & toxicology.
[24] Haruo Watanabe,et al. Vibrio cholerae O1 El Tor and O139 Bengal Strains Carrying ctxBET, Bangladesh , 2013, Emerging infectious diseases.
[25] Haruo Watanabe,et al. Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011. , 2012, Journal of medical microbiology.
[26] Marcus D. Hanwell,et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.
[27] R. Migliani,et al. A cluster of acute diarrhea suspected to be cholera in French travelers in Haiti, December 2010. , 2012, Journal of travel medicine.
[28] Pramod Kumar,et al. Tetracycline resistant V. cholerae O1 biotype El Tor serotype Ogawa with classical ctxB from a recent cholera outbreak in Orissa, Eastern India. , 2012, Journal of infection and public health.
[29] Suranjana Das,et al. Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing , 2010, PloS one.
[30] Firdausi Qadri,et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Torsten Schwede,et al. Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.
[32] L. Singh,et al. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India. , 2008, International journal of antimicrobial agents.
[33] Jing-Tao Wu,et al. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. , 2005, Current topics in medicinal chemistry.
[34] C. Lipinski. Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.
[35] A. Weintraub,et al. Reemergence of Epidemic Vibrio cholerae O139, Bangladesh , 2003, Emerging infectious diseases.
[36] V. DiRita,et al. The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane‐localized transcriptional activators on a single promoter , 2000, Molecular microbiology.
[37] A. Faruque,et al. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae 0139 synonym Bengal , 1993, The Lancet.
[38] Amit Pal,et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India , 1993, The Lancet.